Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06004739 · ClinicalTrials.gov registry record · NA

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

A NA study of Infectious Disease, sponsored by Mount Sinai Hospital, Canada.

Recruiting
Registry status
NA
Development phase
550
Enrollment target
7
Study locations

NCT06004739: Recruiting NA study of Infectious Disease, sponsored by Mount Sinai Hospital, Canada.

NCT06004739 is a NA study of Infectious Disease that is actively recruiting participants, run by Mount Sinai Hospital, Canada. The registered enrollment target is 550 participants, below the 6,994-participant average among 18 other Infectious Disease trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06004739, a NA study of Infectious Disease, is actively recruiting participants, sponsored by Mount Sinai Hospital, Canada.

RECRUITING
Registry status
NA
Development phase
550 participants
Enrollment target
7
Study locations

Study Summary

Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.

Primary Outcome

Delirium will be assessed using Confusion Assessment Method (CAM). CAM assesses 4 delirium features: \[1\] inattention, \[2\] acute and fluctuating level of consciousness, \[3\] disorganized thinking and \[4\] altered mental status. For a diagnosis of delirium by CAM, the patient must display feature \[1\] AND \[2\], AND EITHER \[3\] or \[4\].

Conditions Studied

Interventions

  • DRUG Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
  • OTHER No Antibiotics for treatment of bacteriuria

Study Locations (7)

Other

  • The Ottawa Hospital Civic Campus - Ottawa
  • The Ottawa Hospital General Campus - Ottawa
  • Hennick Bridgepoint Hospital - Toronto
  • Michael Garron Hospital - Toronto
  • Mount Sinai Hospital - Toronto
  • Toronto General Hospital - Toronto

Illinois

  • Northwestern Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2024-05-18
Est. Completion 2027-09
Phase NA
Mount Sinai Hospital, Canada

7 total trials

What NCT06004739 shows while recruiting

NCT06004739 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 6,994-participant average among 18 other Infectious Disease trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 2 interventions - of which Start Antibiotics / Continue Antibiotics for treatment of bacteriuria is the first listed.

NCT06004739 lists 7 locations in 2 states (Other, Illinois).

Frequently Asked Questions

What is clinical trial NCT06004739 about?

NCT06004739 is a clinical study titled "Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection". Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients exp...

What is the current status of trial NCT06004739?

This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2024-05-18. Estimated completion is 2027-09.

What conditions does trial NCT06004739 study?

This clinical trial studies the following conditions: Infectious Disease.

What interventions are being tested in trial NCT06004739?

The interventions under investigation include: Start Antibiotics / Continue Antibiotics for treatment of bacteriuria (DRUG), No Antibiotics for treatment of bacteriuria (OTHER).

Who is sponsoring clinical trial NCT06004739?

This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06004739 being conducted?

This trial has 7 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infectious Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06004739's enrollment target sits among peer trials

550 8th of 18 higher than 11 of 18 other Infectious Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infectious Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06004739, the US trial registry maintained by the National Library of Medicine. NCT06004739 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.